Aerovate Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $81,409,000.
Profit Margin
| 2019 | 0 | -3.33M | |
|---|---|---|---|
| 2020 | 0 | -9.03M | |
| 2021 | 0 | -22.96M | |
| 2022 | 0 | -51.51M | |
| 2023 | 0 | -75.52M |
AVTE Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 96K | 68K | 15K | 1K | 0 |
Gross profit | -96K | -68K | -15K | -1K | 0 |
Operating exp. | |||||
Research and development | 64.21M | 38.62M | 14.98M | 7.94M | 3.11M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 81.40M | 53.23M | 23.02M | 8.88M | 3.33M |
Operating income | -81.40M | -53.23M | -23.02M | -8.88M | -3.33M |
Other income (expenses), net | 5.94M | 1.75M | 62K | -722K | 1K |
Income before tax | -75.46M | -51.48M | -22.96M | -9.61M | -3.33M |
Income tax expense | 56K | 25K | 3K | -572K | 1K |
Net income | -75.52M | -51.51M | -22.96M | -9.03M | -3.33M |
Earnings per share | |||||
Basic EPS | -2.87 | -2.1 | -0.94 | -0.37 | -0.14 |
Diluted EPS | -2.87 | -2.1 | -0.94 | -0.37 | -0.14 |
| Data source | Data source | Data source |